Cargando…
Polypill eligibility and equivalent intake in a Swiss population-based study
The polypill has been advocated for cardiovascular disease (CVD) management. The fraction of the population who could benefit from the polypill in Switzerland is unknown. Assess (1) the prevalence of subjects (a) eligible for the polypill and (b) already taking a polypill equivalent; and (2) the det...
Autores principales: | Castioni, Julien, Abolhassani, Nazanin, Vollenweider, Peter, Waeber, Gérard, Marques-Vidal, Pedro |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Nature Publishing Group UK
2021
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7994372/ https://www.ncbi.nlm.nih.gov/pubmed/33767231 http://dx.doi.org/10.1038/s41598-021-84455-8 |
Ejemplares similares
-
Prevalence and determinants of polypharmacy in Switzerland: data from the CoLaus study
por: Castioni, Julien, et al.
Publicado: (2017) -
Prevalence of measured and reported multimorbidity in a representative sample of the Swiss population
por: Pache, Basile, et al.
Publicado: (2015) -
Socio-demographic and behavioural determinants of weight gain in the Swiss population
por: Guerra, Filipa, et al.
Publicado: (2015) -
Prevalence of atrial fibrillation: The Swiss population-based CoLaus|PsyCoLaus study
por: Samim, Daryoush, et al.
Publicado: (2021) -
Antihypertensive drug treatment changes in the general population: the colaus study
por: Christe, Vanessa, et al.
Publicado: (2014)